CN Stock MarketDetailed Quotes

601089 Beijing Foyou Pharma

Watchlist

14.99
-0.06-0.40%

Not Open Sep 9 15:00 CST

7.20BMarket Cap13.60P/E (TTM)

Beijing Foyou Pharma Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

(Q3)Mar 31, 2022

Assets

Current assets

Money funds

-49.78%1.24B

8.41%2.42B

-0.41%2.53B

25.51%2.5B

11.37%2.47B

351.02%2.23B

484.61%2.54B

--1.99B

403.35%2.22B

--495.32M

Transactional financial assets

--1.06B

----

--360M

----

--370M

----

Notes receivable and accounts receivable

-1.66%344.18M

-7.21%334.08M

-12.70%346.13M

-5.15%358.66M

-9.90%349.98M

-1.87%360.02M

17.30%396.47M

--378.15M

6.66%388.45M

--366.9M

-Accounts receivable

-1.66%344.18M

-7.21%334.08M

-12.70%346.13M

-5.15%358.66M

-9.90%349.98M

-1.87%360.02M

17.30%396.47M

--378.15M

6.66%388.45M

--366.9M

Other receivables (including interest and dividends)

-56.42%1.75M

-31.36%2.39M

-50.12%1.79M

-5.96%3.61M

-18.11%4.03M

-45.48%3.49M

-18.90%3.59M

--3.84M

40.00%4.92M

--6.4M

-Other receivable

-56.42%1.75M

----

-50.12%1.79M

----

-18.11%4.03M

----

-18.90%3.59M

----

--4.92M

----

Advance payment

-2.24%32.77M

49.30%46.26M

137.67%41.7M

42.04%29.26M

3.43%33.52M

15.31%30.98M

-17.17%17.55M

--20.6M

52.25%32.41M

--26.87M

Inventories

-0.85%336.05M

-3.32%329.51M

-9.34%307.42M

-9.04%304.44M

-1.00%338.95M

3.11%340.82M

4.66%339.1M

--334.71M

6.40%342.37M

--330.54M

Receivable financing

5.48%72.21M

-9.67%70.33M

38.31%98.44M

53.35%88.16M

24.67%68.46M

121.92%77.86M

33.71%71.18M

--57.49M

54.77%54.91M

--35.09M

Other current assets

-21.73%2.69M

-22.73%2.88M

-24.56%2.45M

-15.57%4.49M

-38.40%3.44M

-12.08%3.73M

-16.77%3.24M

--5.32M

-42.99%5.59M

--4.25M

Total current assets

-5.47%3.09B

-5.97%3.21B

-1.29%3.33B

3.99%3.29B

7.29%3.27B

169.56%3.41B

163.59%3.37B

--3.16B

154.62%3.05B

--1.27B

Non Current assets

Fixed assets

0.94%677.7M

----

0.49%678.54M

----

20.29%671.36M

----

18.95%675.26M

----

--558.1M

----

Constru in process

159.52%361.22M

----

447.17%255.66M

----

11.61%139.19M

----

-53.30%46.72M

----

--124.7M

----

Intangible assets

5.08%144.46M

5.06%147.18M

5.32%150.2M

-7.14%134.88M

-2.70%137.48M

-1.22%140.08M

-1.13%142.61M

--145.24M

-4.25%141.3M

--141.82M

Long deferred expense

-19.75%22.27M

-18.34%23.74M

29.88%22.92M

3,338.43%26.03M

3,333.28%27.75M

9,704.24%29.07M

5,267.41%17.65M

--757.04K

621.85%808.14K

--296.52K

Deferred tax assets

-77.29%2.43M

-51.75%2.48M

-40.51%2.81M

76.78%10.8M

81.65%10.71M

10.06%5.15M

7.61%4.72M

--6.11M

34.37%5.9M

--4.68M

Usufruct assets

-31.58%40.47M

-16.78%44.84M

-14.85%49.21M

-12.45%54.64M

-9.02%59.15M

-10.37%53.88M

7.06%57.79M

--62.41M

436.08%65.02M

--60.11M

Other non current assets

229.28%97.63M

864.15%98.93M

1,129.21%59.71M

244.85%50.32M

101.32%29.65M

9.98%10.26M

57.64%4.86M

--14.59M

112.44%14.73M

--9.33M

Total non current assets

25.19%1.35B

31.46%1.29B

28.37%1.22B

24.61%1.16B

18.09%1.08B

10.44%978.64M

8.68%949.61M

--932.19M

15.73%910.55M

--886.15M

Total assets

2.12%4.44B

2.38%4.49B

5.22%4.55B

8.69%4.45B

9.77%4.34B

104.02%4.39B

100.73%4.32B

--4.09B

99.53%3.96B

--2.15B

Liabilities

Current liabilities

Short term loan

-9.28%49.94M

-33.48%49.94M

37.46%55.05M

7.14%75.07M

-42.86%40.05M

--40.04M

-80.00%40.04M

--70.07M

Notes payable and accounts payable

8.13%127.44M

-1.87%119.02M

-7.89%132.18M

6.12%121.03M

-6.34%117.86M

11.31%121.28M

10.59%143.51M

--114.06M

9.82%125.83M

--108.96M

-Accounts payable

8.13%127.44M

-1.87%119.02M

-7.89%132.18M

6.12%121.03M

-6.34%117.86M

11.31%121.28M

10.59%143.51M

--114.06M

9.82%125.83M

--108.96M

Contract liabilities

47.35%74.08M

66.38%64.78M

-50.91%39.74M

-7.80%31.73M

47.59%50.28M

-10.48%38.93M

89.05%80.96M

--34.42M

0.36%34.07M

--43.49M

Advance receipts

--517.4K

17,050.71%514.52K

2,528.33%78.85K

----

--3K

----

Salaries payable

4.93%102.93M

3.15%73.95M

9.85%135.74M

12.41%110.57M

13.00%98.09M

-1.64%71.7M

17.12%123.57M

--98.36M

22.18%86.8M

--72.89M

Taxs payable

-23.28%29.76M

-30.20%36.24M

-47.19%42.99M

-33.77%48.38M

-37.13%38.79M

-7.65%51.92M

52.43%81.4M

--73.04M

75.63%61.7M

--56.22M

Other payable (including interest and dividends)

-8.40%553.04M

-6.87%565.13M

1.40%537.49M

10.10%572.97M

14.27%603.78M

26.24%606.83M

24.82%530.07M

--520.39M

33.75%528.4M

--480.69M

-Other payable

-8.40%553.04M

----

1.40%537.49M

----

14.27%603.78M

----

24.82%530.07M

----

--528.4M

----

Non current liabilities due within one year

-5.39%21.6M

18.79%22.8M

16.05%24.61M

-21.84%22.5M

-21.97%22.83M

6.28%19.2M

20.71%21.21M

--28.78M

32.30%29.26M

--18.06M

Other current liabilities

17.64%27.87M

37.08%31.48M

-5.40%30.49M

24.14%26.99M

48.89%23.69M

26.17%22.96M

42.26%32.23M

--21.74M

-19.48%15.91M

--18.2M

Total current liabilities

-2.29%987.18M

-4.37%963.86M

-5.19%998.38M

6.27%989.21M

9.58%1.01B

16.04%1.01B

21.53%1.05B

--930.84M

3.38%922.01M

--868.59M

Current liabilities

Long term loan

-33.33%9.9M

-28.57%12.37M

-28.58%12.37M

38.33%14.85M

38.28%14.85M

-2.37%17.32M

137.90%17.33M

--10.73M

--10.74M

--17.74M

Deferred tax liabilities

-35.28%18.75M

-6.91%18.45M

-3.33%18.22M

73.97%29.45M

69.56%28.98M

18.32%19.82M

11.58%18.85M

--16.93M

24.65%17.09M

--16.75M

Long term deferred income

-7.19%9.86M

10.25%10.19M

5.43%10.02M

6.35%10.33M

56.24%10.63M

34.20%9.24M

129.38%9.5M

--9.71M

113.11%6.8M

--6.89M

Lease liabilities

-39.93%26.03M

-33.46%27.79M

-27.23%32.26M

-21.53%38.47M

-14.60%43.32M

-13.48%41.76M

2.96%44.33M

--49.03M

526.43%50.73M

--48.26M

Total non current liabilities

-33.99%64.54M

-21.95%68.8M

-19.04%72.88M

7.75%93.09M

14.55%97.78M

-1.68%88.14M

26.11%90.01M

--86.39M

241.42%85.36M

--89.64M

Total liabilities

-5.09%1.05B

-5.78%1.03B

-6.28%1.07B

6.40%1.08B

10.00%1.11B

14.38%1.1B

21.87%1.14B

--1.02B

9.87%1.01B

--958.24M

Shareholders equity

Paid-in capital

0.00%480M

33.33%480M

--480M

33.33%480M

--360M

Capital reserve funds

0.00%1.66B

1,034.95%1.66B

--1.66B

1,034.95%1.66B

--146.47M

Surplus reserve funds

33.83%154.18M

33.69%154.18M

33.67%154.18M

47.04%115.21M

47.19%115.33M

47.21%115.34M

--78.35M

46.61%78.35M

--78.35M

Retained profit

26.87%1.22B

27.31%1.29B

28.61%1.16B

30.81%1.09B

35.65%957.78M

73.40%1.01B

48.35%901.58M

--831.11M

45.61%706.09M

--585.32M

Less:Treasury stock

--148.63M

----

Specific reserves

-18.63%12.09M

-18.34%12.15M

-18.31%12.34M

-28.19%12.4M

-20.72%14.86M

-21.26%14.88M

-20.28%15.1M

--17.27M

-1.52%18.75M

--18.9M

Shareholders equity without minority interests

4.49%3.38B

5.01%3.45B

9.26%3.47B

9.39%3.36B

9.66%3.23B

176.48%3.29B

162.03%3.17B

--3.07B

176.87%2.95B

--1.19B

Minority interests

56.36%9.94M

51.47%9.07M

78.41%8.12M

41.22%7.71M

26.12%6.36M

41.37%5.99M

18.76%4.55M

--5.46M

72.13%5.04M

--4.24M

Total shareholder equity

4.59%3.39B

5.09%3.46B

9.36%3.48B

9.44%3.36B

9.69%3.24B

176.00%3.29B

161.57%3.18B

--3.07B

176.58%2.95B

--1.19B

Total liabilityies and equity

2.12%4.44B

2.38%4.49B

5.22%4.55B

8.69%4.45B

9.77%4.34B

104.02%4.39B

100.73%4.32B

--4.09B

99.53%3.96B

--2.15B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Tianjian Certified Public Accountants (Special General Partnership)

	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022	(Q3)Mar 31, 2022
Assets
Current assets
Money funds	-49.78%1.24B	8.41%2.42B	-0.41%2.53B	25.51%2.5B	11.37%2.47B	351.02%2.23B	484.61%2.54B	--1.99B	403.35%2.22B	--495.32M
Transactional financial assets	--1.06B	----	----	----	----	--360M	----	--370M	----	----
Notes receivable and accounts receivable	-1.66%344.18M	-7.21%334.08M	-12.70%346.13M	-5.15%358.66M	-9.90%349.98M	-1.87%360.02M	17.30%396.47M	--378.15M	6.66%388.45M	--366.9M
-Accounts receivable	-1.66%344.18M	-7.21%334.08M	-12.70%346.13M	-5.15%358.66M	-9.90%349.98M	-1.87%360.02M	17.30%396.47M	--378.15M	6.66%388.45M	--366.9M
Other receivables (including interest and dividends)	-56.42%1.75M	-31.36%2.39M	-50.12%1.79M	-5.96%3.61M	-18.11%4.03M	-45.48%3.49M	-18.90%3.59M	--3.84M	40.00%4.92M	--6.4M
-Other receivable	-56.42%1.75M	----	-50.12%1.79M	----	-18.11%4.03M	----	-18.90%3.59M	----	--4.92M	----
Advance payment	-2.24%32.77M	49.30%46.26M	137.67%41.7M	42.04%29.26M	3.43%33.52M	15.31%30.98M	-17.17%17.55M	--20.6M	52.25%32.41M	--26.87M
Inventories	-0.85%336.05M	-3.32%329.51M	-9.34%307.42M	-9.04%304.44M	-1.00%338.95M	3.11%340.82M	4.66%339.1M	--334.71M	6.40%342.37M	--330.54M
Receivable financing	5.48%72.21M	-9.67%70.33M	38.31%98.44M	53.35%88.16M	24.67%68.46M	121.92%77.86M	33.71%71.18M	--57.49M	54.77%54.91M	--35.09M
Other current assets	-21.73%2.69M	-22.73%2.88M	-24.56%2.45M	-15.57%4.49M	-38.40%3.44M	-12.08%3.73M	-16.77%3.24M	--5.32M	-42.99%5.59M	--4.25M
Total current assets	-5.47%3.09B	-5.97%3.21B	-1.29%3.33B	3.99%3.29B	7.29%3.27B	169.56%3.41B	163.59%3.37B	--3.16B	154.62%3.05B	--1.27B
Non Current assets
Fixed assets	0.94%677.7M	----	0.49%678.54M	----	20.29%671.36M	----	18.95%675.26M	----	--558.1M	----
Constru in process	159.52%361.22M	----	447.17%255.66M	----	11.61%139.19M	----	-53.30%46.72M	----	--124.7M	----
Intangible assets	5.08%144.46M	5.06%147.18M	5.32%150.2M	-7.14%134.88M	-2.70%137.48M	-1.22%140.08M	-1.13%142.61M	--145.24M	-4.25%141.3M	--141.82M
Long deferred expense	-19.75%22.27M	-18.34%23.74M	29.88%22.92M	3,338.43%26.03M	3,333.28%27.75M	9,704.24%29.07M	5,267.41%17.65M	--757.04K	621.85%808.14K	--296.52K
Deferred tax assets	-77.29%2.43M	-51.75%2.48M	-40.51%2.81M	76.78%10.8M	81.65%10.71M	10.06%5.15M	7.61%4.72M	--6.11M	34.37%5.9M	--4.68M
Usufruct assets	-31.58%40.47M	-16.78%44.84M	-14.85%49.21M	-12.45%54.64M	-9.02%59.15M	-10.37%53.88M	7.06%57.79M	--62.41M	436.08%65.02M	--60.11M
Other non current assets	229.28%97.63M	864.15%98.93M	1,129.21%59.71M	244.85%50.32M	101.32%29.65M	9.98%10.26M	57.64%4.86M	--14.59M	112.44%14.73M	--9.33M
Total non current assets	25.19%1.35B	31.46%1.29B	28.37%1.22B	24.61%1.16B	18.09%1.08B	10.44%978.64M	8.68%949.61M	--932.19M	15.73%910.55M	--886.15M
Total assets	2.12%4.44B	2.38%4.49B	5.22%4.55B	8.69%4.45B	9.77%4.34B	104.02%4.39B	100.73%4.32B	--4.09B	99.53%3.96B	--2.15B
Liabilities
Current liabilities
Short term loan	-9.28%49.94M	-33.48%49.94M	37.46%55.05M	37.46%55.05M	37.46%55.05M	7.14%75.07M	-42.86%40.05M	--40.04M	-80.00%40.04M	--70.07M
Notes payable and accounts payable	8.13%127.44M	-1.87%119.02M	-7.89%132.18M	6.12%121.03M	-6.34%117.86M	11.31%121.28M	10.59%143.51M	--114.06M	9.82%125.83M	--108.96M
-Accounts payable	8.13%127.44M	-1.87%119.02M	-7.89%132.18M	6.12%121.03M	-6.34%117.86M	11.31%121.28M	10.59%143.51M	--114.06M	9.82%125.83M	--108.96M
Contract liabilities	47.35%74.08M	66.38%64.78M	-50.91%39.74M	-7.80%31.73M	47.59%50.28M	-10.48%38.93M	89.05%80.96M	--34.42M	0.36%34.07M	--43.49M
Advance receipts	--517.4K	17,050.71%514.52K	2,528.33%78.85K	----	----	--3K	--3K	----	----	----
Salaries payable	4.93%102.93M	3.15%73.95M	9.85%135.74M	12.41%110.57M	13.00%98.09M	-1.64%71.7M	17.12%123.57M	--98.36M	22.18%86.8M	--72.89M
Taxs payable	-23.28%29.76M	-30.20%36.24M	-47.19%42.99M	-33.77%48.38M	-37.13%38.79M	-7.65%51.92M	52.43%81.4M	--73.04M	75.63%61.7M	--56.22M
Other payable (including interest and dividends)	-8.40%553.04M	-6.87%565.13M	1.40%537.49M	10.10%572.97M	14.27%603.78M	26.24%606.83M	24.82%530.07M	--520.39M	33.75%528.4M	--480.69M
-Other payable	-8.40%553.04M	----	1.40%537.49M	----	14.27%603.78M	----	24.82%530.07M	----	--528.4M	----
Non current liabilities due within one year	-5.39%21.6M	18.79%22.8M	16.05%24.61M	-21.84%22.5M	-21.97%22.83M	6.28%19.2M	20.71%21.21M	--28.78M	32.30%29.26M	--18.06M
Other current liabilities	17.64%27.87M	37.08%31.48M	-5.40%30.49M	24.14%26.99M	48.89%23.69M	26.17%22.96M	42.26%32.23M	--21.74M	-19.48%15.91M	--18.2M
Total current liabilities	-2.29%987.18M	-4.37%963.86M	-5.19%998.38M	6.27%989.21M	9.58%1.01B	16.04%1.01B	21.53%1.05B	--930.84M	3.38%922.01M	--868.59M
Current liabilities
Long term loan	-33.33%9.9M	-28.57%12.37M	-28.58%12.37M	38.33%14.85M	38.28%14.85M	-2.37%17.32M	137.90%17.33M	--10.73M	--10.74M	--17.74M
Deferred tax liabilities	-35.28%18.75M	-6.91%18.45M	-3.33%18.22M	73.97%29.45M	69.56%28.98M	18.32%19.82M	11.58%18.85M	--16.93M	24.65%17.09M	--16.75M
Long term deferred income	-7.19%9.86M	10.25%10.19M	5.43%10.02M	6.35%10.33M	56.24%10.63M	34.20%9.24M	129.38%9.5M	--9.71M	113.11%6.8M	--6.89M
Lease liabilities	-39.93%26.03M	-33.46%27.79M	-27.23%32.26M	-21.53%38.47M	-14.60%43.32M	-13.48%41.76M	2.96%44.33M	--49.03M	526.43%50.73M	--48.26M
Total non current liabilities	-33.99%64.54M	-21.95%68.8M	-19.04%72.88M	7.75%93.09M	14.55%97.78M	-1.68%88.14M	26.11%90.01M	--86.39M	241.42%85.36M	--89.64M
Total liabilities	-5.09%1.05B	-5.78%1.03B	-6.28%1.07B	6.40%1.08B	10.00%1.11B	14.38%1.1B	21.87%1.14B	--1.02B	9.87%1.01B	--958.24M
Shareholders equity
Paid-in capital	0.00%480M	0.00%480M	0.00%480M	0.00%480M	0.00%480M	33.33%480M	33.33%480M	--480M	33.33%480M	--360M
Capital reserve funds	0.00%1.66B	0.00%1.66B	0.00%1.66B	0.00%1.66B	0.00%1.66B	1,034.95%1.66B	1,034.95%1.66B	--1.66B	1,034.95%1.66B	--146.47M
Surplus reserve funds	33.83%154.18M	33.69%154.18M	33.67%154.18M	47.04%115.21M	47.04%115.21M	47.19%115.33M	47.21%115.34M	--78.35M	46.61%78.35M	--78.35M
Retained profit	26.87%1.22B	27.31%1.29B	28.61%1.16B	30.81%1.09B	35.65%957.78M	73.40%1.01B	48.35%901.58M	--831.11M	45.61%706.09M	--585.32M
Less:Treasury stock	--148.63M	--148.63M	----	----	----	----	----	----	----	----
Specific reserves	-18.63%12.09M	-18.34%12.15M	-18.31%12.34M	-28.19%12.4M	-20.72%14.86M	-21.26%14.88M	-20.28%15.1M	--17.27M	-1.52%18.75M	--18.9M
Shareholders equity without minority interests	4.49%3.38B	5.01%3.45B	9.26%3.47B	9.39%3.36B	9.66%3.23B	176.48%3.29B	162.03%3.17B	--3.07B	176.87%2.95B	--1.19B
Minority interests	56.36%9.94M	51.47%9.07M	78.41%8.12M	41.22%7.71M	26.12%6.36M	41.37%5.99M	18.76%4.55M	--5.46M	72.13%5.04M	--4.24M
Total shareholder equity	4.59%3.39B	5.09%3.46B	9.36%3.48B	9.44%3.36B	9.69%3.24B	176.00%3.29B	161.57%3.18B	--3.07B	176.58%2.95B	--1.19B
Total liabilityies and equity	2.12%4.44B	2.38%4.49B	5.22%4.55B	8.69%4.45B	9.77%4.34B	104.02%4.39B	100.73%4.32B	--4.09B	99.53%3.96B	--2.15B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--	--
Auditor	--	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

601089 Beijing Foyou Pharma

Beijing Foyou Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target